drugset

drugset / Trial / NCT02239926

Effect of Ranolazine on Gastrointestinal Motor Function and Pain in Patients With IBS-D

NCT02239926 ↗

Phase 2/3 Terminated 5 enrolled Mayo Clinic

RandomizedParallel-groupTriple-blindTreatment

Summary

Will Ranolazine improve bowel function and abdominal pain in human subjects with IBS-D?

Timeline

Start: 2014-09
Primary completion: 2015-09
Completion: 2015-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Ranolazine	Small molecule	1000 mg	Oral

Indications